Matches in Nanopublications for { ?s ?p "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP272378.RAcCCtshQV-tLCr8WGMWkjJH9nnxuoq6Me-ShTcHd2rEU130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272378.RAcCCtshQV-tLCr8WGMWkjJH9nnxuoq6Me-ShTcHd2rEU130_provenance.
- NP824236.RACJPlqcF9F20lPoeplKNtGlGmYBuimp1oSNG9uo7GInw130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824236.RACJPlqcF9F20lPoeplKNtGlGmYBuimp1oSNG9uo7GInw130_provenance.
- NP183008.RAmKwJ2QITozkdahNOKcXKMZISDWCNTxOHlveihIVhwqc130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183008.RAmKwJ2QITozkdahNOKcXKMZISDWCNTxOHlveihIVhwqc130_provenance.
- assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP718985.RAz8FScLeQDz_SSFQ4Ti4vts4dvuSPOnwSdPEmON4rmC8130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718985.RAz8FScLeQDz_SSFQ4Ti4vts4dvuSPOnwSdPEmON4rmC8130_provenance.
- NP518347.RAcU6hbB-eY-rPeEeK1x2Rz38yy05ZTvtiIbU6JHbRxiE130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518347.RAcU6hbB-eY-rPeEeK1x2Rz38yy05ZTvtiIbU6JHbRxiE130_provenance.
- NP518349.RAci6rfeuV_BojjuZSH8BczgP1SpLvz9KxXY86lIFth-0130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518349.RAci6rfeuV_BojjuZSH8BczgP1SpLvz9KxXY86lIFth-0130_provenance.
- assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP518348.RAiULWTljfje3e5gLq9DxqIM7WThvbbl8ee5ZK4ztq7pM130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518348.RAiULWTljfje3e5gLq9DxqIM7WThvbbl8ee5ZK4ztq7pM130_provenance.
- NP518350.RA0-ot7CeiPCOKj-bFcAjqK2mv8xjcnLL327yaT4Lb5zc130_assertion description "[A single lysine-to-arginine point mutation (K209R) derived from prostate cancer reduces acetylation of KLF6 and abrogates its capacity to up-regulate endogenous p21(WAF1/cip1) and reduce cell proliferation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518350.RA0-ot7CeiPCOKj-bFcAjqK2mv8xjcnLL327yaT4Lb5zc130_provenance.